Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
This was not Shark Tank. It is a photo from ArcVeiw investor forum, he was asked to be there due to his experience with marijuana and investor relations related to it. So what is the point of this false post?
Agreed. But subtract bad taste in the mouth and 6 is more realistic...
No. But not likely before you would have an opportunity to get out with your money.
Even with DRYS spending as fast as they get it, the company is fundamentally much better now than last run. That with the index gaining ground I would say 4 to 6 is not out of the question.
It'll run. Market floor is teaming with vultures.
It is not news. Only a quotation. This was the purpose of 2 years + beta testing. MYDX has also created a social media platform to categorize testing data. In short MYDX is preforming a crowd based medical study from analyzer data.
I know for a fact that they sold more than Zero last week but am not at liberty to discuss this publicly. In of my corporations is wholesale only. I have 10 regional sales staff which have an average of 48 retail centers each. Those individual centers have an average of 27 full-time salespeople. Math tells you I have 12960 people selling my product. MYDX works the same, only difference is they also do retail online sales.
Y'all have a great Monday! I am going to enjoy 80° fishing today. Suppose to rain next couple days
You know how I know it's manipulation? I have a 1mil order on the ask which has not been filled even partial nor does it show on L2
Agreed. They have the potential to show an up tick in The 4th and a shot up in the 1st.
Anytime you see a big spread with large buys on the ask then some small sells below the bid it is MM games only. Take advantage for certain of cheap buys.
More L2 games today. The manipulation is comical.
How many CEO's do you know? They have sales staff for this. If a CEO is closing an order it is significant...
This is incorrect. I have used the testing methods here. As with any test, lab or not, you will have more accurate results if you do multiple tests on the same sample and analyze the data.
MYDX facts:
The people involved with this are accomplished professionals with resumes to prove it.
Beta testing started around 2 years ago.
Yes they used "toxic financing" to get this product to market. This is used by many startups yet few navigate through it as successfully as MYDX has thus far.
There are other analyzers on the market but not this compact or even close to the price.
Yes this product has patents protecting the tech and no it doesn't matter who's name is on it as long as they hold the licensing which they do.
Yes it uses some existing technology, some proprietary technology and some living technology. The latter being the reason you will see multiple versions in the future.
Some of the beta reviews have been addressed others will be addressed in subsequent versions (like Apple, Samsung, Panasonic do as well)
MYDX has a functional product on the market with support teams for it.
MYDX has adequate production and distribution capabilities for the foreseeable future.
By leveraging outside manufacturing and sales they can focus on R&D and future roll-out with minimal staffing (this is called lean management).
The analyzer works as advertised for what it is intended.
Yes it can be tricked or misused as is with any analyzer I know of. This is why the market will be regulated just like alcohol and tobacco in the near future.
MYDX cannabis analyzer is also a profiler which enables the user to catalog results of products they would like to repurchase. Now because of the many variables in the strains, environment, harvest process, time to consumer, etc. it is possible your next purchase may find you buying another product altogether based on that profile.
Again, this process uses proprietary, existing and living databases to achieve this.
Anything is only of value if there is a market for it and there is a proven market in multiple arenas for a device of this type.
MYDX is first to market with this device. That is not a guarantee but it is a better start than most companies receive.
MYDX has multiple units in various stages of R&D within the same general spectrum yet covering a much larger total market.
Do your own DD and you will find nothing is perfect here and mistakes have been made. But compare it to other OTC investments and see how it stacks up. Good luck to you all!
This is social media to be sure. I did however sling BS outta the back of a tractor in my younger years...
Cattle but is just a pastime really. Chemical engineer and business.
A very lucky man that traded one boat anchor for another just in time to enjoy my life. Oh and wasn't kidding about the lucky part. Found oil on my property...
Still at the ranch but leaving on a jet plane at 8pm. Do pass up the chance Belize is beautiful!
Microcap conferences are not just tea and crumpets...
Just MM trading monopoly money. Buy low if you want more. Hold and ignore false L2. But enjoy this beautiful weekend!
Let the L2 games begin! One more day on the ranch then back to Belize. See you all around the 17th or maybe sooner...
.05 could be a reach... lol
Almost time to start buying DRYS again. Was a awesome money maker last year for me.
More opinions by the CEO of MYDX
You can find the agreement and patents in the 8-K April 24, 2015 agreement. He is co-inventor on some from previous employement and CDx holds some as well for the device.
Thank you for the response. Honestly more than I was will to do for the millionth time here. What you mentioned here is also why the agreement with NDT licensed use of their patented "nose tech". But marijuana is the smallest market for this technology in reality.
FYI, cannabis is only the simplest thing to bring to market. It is not the scope of the product development. You think they wanted nose tech to sniff pot? Really I could sell you a dog for that...
Read up and get back to me. Not just Yazbeck but his partners as well.
Companies are only run on constant PR in the OTC. They should only grow at a normal rate as most do. Unfortunately people spend their lunch money trying to make a quick profit. If you need the money by all means sell. Please! Ok I am out for the day.
I am going into a meeting here I will pull it off my computer after and send it to you.
If you have been around a while you know this is just the MM playing with the stock. You can calculate how many are in this and what is moving around for yourself and determine it is not your large long term positions moving. Just games here.
Agreed prediction is for fortune telling. At .012 I am almost 700k to the good. Thats all the prediction I need...
It has been in development for 10+ years. Yazbeck just patented the delivery system for the tech.
Your on the right track. This is also why they got involved with New Dimension for the "breath detection". Yazbeck already knew why and how it could be used with his system. As I said, follow the patents for all this tech and you will find it's a small circle and a few people hold key parts of the total package.
This is a profiler as well as an analyzer, meaning it will take what strain (regardless of why) and allows you to store that profile for reference in matching this strains properties for future purchase. MYDX analyzer is exactly that, it analyzes information given, so just like computers and people "garbage in garbage out". A commercial testing device such as the one used at WSU to test my ranches alfalfa are completely different. Because of the legality issue and the university's federal funding it cannot test Marijuana. In Washington State, Marijuana will be treated much like alcohol as far as labeling an % requirements. So we will have to post and prove labeled regulations as well as other data just like anything for human consumption. This will become a federally adopted process in time. I am in Canada right now and it appears they are largely going follow what the US adopts since it will be a huge market for them as well. Regardless this is an expense the average consumer cannot afford to test for in a lab type environment. So the inexpensive analyzer makes sense, although obviously not as accurate as a lab, will give you a profile to compare against. So even if the reading was not 100% accurate, if the product gave to you the desired effect you could as a consumer locate this type of product again much more accurately than guessing. It does a couple other things that are of advantage to the consumer also. The cannalyzer 420 is extremely expensive and not near as accurate as a lab device. Proper testing requires the following:
http://www.aafp.org/practice-management/regulatory/clia/manual.html
None of which can be performed in a setting anything other than a lab for the sake of control. So your argument is as baseless as it is inaccurate.
Obviously I am not a fan of dilution but sometimes it is a necessary evil. What is done with it and how efficiently the funds are used and returned is more what should be looked at. No new company is perfect nor do they not misstep but recovery is the gauge. So far for the limited time MYDX has been around they are leaps and bounds above most OTC companies if you are just here for the short term.
This is where the real money is in MYDX. This is also why it is taking time to develop. You test for minerals, chemicals, bacteria, bio-hazards, etc. by different means. It takes some time to make this handheld. It is very close to there and that is why you see the big buying. Marijuana was just the first to market is all.
http://www.ewg.org/research/bottled-water-quality-investigation/test-results-chemicals-bottled-water
http://earlywarninginc.com/biohazards.php